PhRMA
AUGUST 10, 2022
Last weekend, the Senate passed the Inflation Reduction Act which includes dangerous price-setting provisions. The bill now heads to the House for consideration, where it is not too late for them to stand up for patients and medical innovation by opposing the bill.
Pharmacy Is Right For Me
AUGUST 10, 2022
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To highlight some of the more unique career settings in the industry, we’re introducing a new page on our website— Novel Pharmacy Practice Settings —where you can explore these unique career pathways. In addition to learning more about unique pathways on our new webpage, we’ll also be featuring pharmacists who work in these unique settings on our blog.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
AUGUST 10, 2022
We need to move toward a more value-driven health care system that centers around patients’ needs. Sound evidence can help guide us toward that, and we’re committed to developing tools to help patients, physicians and others make informed decisions.
Pharmacy Times
AUGUST 10, 2022
Meta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmExec
AUGUST 10, 2022
Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting. What is being done to smooth the path for pricing and reimbursement?
Pharmacy Times
AUGUST 10, 2022
Survey finds that 91% of health care providers and 67% of people with migraines feel that individuals who are able to successfully manage stress and mental health conditions can also better manage the symptoms of migraine.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 10, 2022
Pharmacists can play an important role in helping ensure compliance with prescribed medications, which can help seniors maintain their health and quality of life while aging at home.
PharmaVoice
AUGUST 10, 2022
Miruna Sasu is on a mission to use real world data to help wipe out cancer. She believes this audacious goal is within reach, and as president and CEO of COTA, she is inspiring her team to create a “path to care” for oncology patients.
Pharmacy Times
AUGUST 10, 2022
Investigators from NYU’s Grossman School of Medicine sound alarm on treatment gap and suggest ways to remove barriers, as opioid overdoses soar to historic levels.
Pharmaceutical Commerce
AUGUST 10, 2022
Recognizing the sustainability issue is an important step, but the biopharmaceutical sector encompasses a complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 10, 2022
A new study predicts significant increases in cardiovascular issues in the United States, highlighting racial and ethnic inequality of future patients.
Pharmaceutical Technology
AUGUST 10, 2022
Cerevance has entered a multi-year strategic research partnership with Merck (MSD outside North America) to discover new targets for Alzheimer’s disease. Under the alliance, the companies will use the Nuclear Enriched Transcript Sort sequencing (NETSseq) technology platform of Cerevance to identify the targets. Furthermore, Cerevance will simultaneously out-license a discovery-stage programme to Merck under the partnership.
Pharmacy Times
AUGUST 10, 2022
Analysis supports positive lifestyle habits, such as exercising and quitting smoking, investigators say.
The Guardian - Pharmaceutical Industry
AUGUST 10, 2022
The pharmacy chain failed to properly investigate suspicious opioid orders, according to federal ruling Walgreens “substantially contributed” to San Francisco’s opioid epidemic by failing to perform due diligence on prescriptions that flooded into the city for 15 years, a federal judge has found. The city won what local media has called a “ landmark trial ” against Walgreens, with the judge, Charles Breyer, finding that the pharmacy chain had failed to properly investigate suspicious opioid orde
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
AUGUST 10, 2022
The technology is not just about digital enablement anymore.
European Pharmaceutical Review
AUGUST 10, 2022
In order to meet microbiological quality standards, herbal medicine pills are often irradiated at the primary package or final product stage. Radiation is chosen over thermal terminal sterilisation to minimise decomposition of crude drug components, volatilisation of essential oils and changes in colour. However, with limited evidence on the impact ionising radiation has on the constituents of such products, researchers set out to investigate whether irradiation impacts drug quality beyond micro
PharmExec
AUGUST 10, 2022
Failed efforts do not overshadow field’s progress, resolve.
European Pharmaceutical Review
AUGUST 10, 2022
Gilead Sciences has signed a definitive agreement to acquire outstanding share capital of clinical-stage biotechnology company MiroBio for around $405 million. The deal includes MiroBio’s proprietary I-ReSToRE ( RE ceptor S election and T argeting t o R einstate immune E quilibrium) discovery platform and its entire portfolio of immune inhibitory receptor agonists.
Pharmacy Times
AUGUST 10, 2022
Although the guidance has created some confusion around pharmacists’ responsibilities on the federal and state levels, Lanton said it will take time to find cohesive solutions.
European Pharmaceutical Review
AUGUST 10, 2022
Amgen has entered into a definitive agreement to acquire ChemoCentryx Inc., a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Under the agreement, ChemoCentryx will be acquired for $52 per share in cash, for a total enterprise value of approximately $3.7 billion. “The acquisition of ChemoCentryx represents a compelling opportunity for Amgen to add to our decades-long leadership in inflammation and nephro
Pharmacy Times
AUGUST 10, 2022
Cangrelor (Kengreal) is indicated as an adjunct to percutaneous coronary intervention for reducing the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis.
PharmExec
AUGUST 10, 2022
How one company in particular has adjusted its internal and customer-facing strategies in compliance training amid today’s heightened business-risk climate.
Pharmacy Times
AUGUST 10, 2022
Heidi D. Finnes, PharmD, BCOP, FHOPA, president-elect of Hematology/Oncology Pharmacy Association (HOPA), explains how HOPA can help prepare PGY2 pharmacy residents to obtain and maintain their BCOP certification.
PharmExec
AUGUST 10, 2022
Major stakeholders—including policymakers, public-private interests, and academia—are increasingly embracing the potential of proteomics technology in reshaping diagnostics and patient care.
Pharmacy Times
AUGUST 10, 2022
Health care professionals need to work closely with patients in understanding polypharmacy and the risk/benefit of pharmacotherapy.
Pharmaceutical Technology
AUGUST 10, 2022
Catale n t has signed an agreement for the acquisition of full-service specialty Contract Development and Manufacturing Organization (CDMO) Metrics Contract Services for $475m from Mayne Pharma. The takeover of Metrics will bolster the expertise of Catalent in the development of integrated oral solid formulation, production and packaging to aid customers in streamlining and expediting their programmes.
Pharmacy Times
AUGUST 10, 2022
Part 3 in a series outlining 5 crucial steps pharmacies can take to enhance patient engagement and lower operational costs.
PQA
AUGUST 10, 2022
PQA follows a systematic, transparent and consensus-based development?process?to ensure that measures are important, scientifically acceptable, feasible and usable. However, the measurement lifecycle does not end when a measure is endorsed. Previous blogs have?walked through?the?measure conceptualization,?measure specification and measure?testing and measure endorsement phases?
PharmExec
AUGUST 10, 2022
Innovative and continuous remote patient monitoring, along with AI-based predictive analytics, are advancing progress toward replacing the one-size-fits-all, population-driven vaccination model.
Pharmaceutical Technology
AUGUST 10, 2022
North America extended its dominance for artificial intelligence (AI) hiring among pharmaceutical industry companies in the three months ending June. The number of roles in North America made up 53.2% of total AI jobs - up from 47.6% in the same quarter last year. That was followed by Asia-Pacific, which saw a 0.9 year-on-year percentage point change in AI roles.
PharmExec
AUGUST 10, 2022
The BCG Market Access Roundtable outlines the new and advanced access competencies required to enable functional operationalization and delivery of this critical role in biopharma—today a key strategic partner in achieving overall business goals.
Pharmaceutical Technology
AUGUST 10, 2022
The proportion of pharmaceutical companies hiring for industrial automation related positions rose in July 2022 compared with the equivalent month last year, with 58.3% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 48.8% of companies who were hiring for industrial automation related jobs a year ago and an increase compared to the figure of 53.9% in June 2022.
PharmExec
AUGUST 10, 2022
A review of pharma and biotech equity market, IPO, and M&A trends and outputs through the first half of 2022—and implications for the future as disruptions continue to have an impact.
Pharmaceutical Technology
AUGUST 10, 2022
Working with a contract manufacturing organization (CMO) in the pursuit of bringing a new product to market can deliver a range of significant benefits. A good CMO can assist with everything from clinical supply and formulation challenges to risk mitigation, as well as general challenges that can arise through the scale-up process, such as market demand fluctuation.
Expert insights. Personalized for you.
197 
Let's personalize your content